CGAs can regulate NF-κB and PPARα pathways, lower HIF-1α expression, and suppress cardiac apoptotic signaling, thus executing beneficial effects against cardiac hypertrophy and heart failure (HF) [2]. The gene discussed is NFKB1; the disease is hydrops fetalis.